GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (OTCPK:AULSF) » Definitions » Price-to-Owner-Earnings

Austar Lifesciences (Austar Lifesciences) Price-to-Owner-Earnings : (As of Jun. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Austar Lifesciences Price-to-Owner-Earnings?

As of today (2024-06-01), Austar Lifesciences's share price is $0.005. Austar Lifesciences does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Austar Lifesciences's Price-to-Owner-Earnings or its related term are showing as below:

During the past 11 years, the highest Price-to-Owner-Earnings of Austar Lifesciences was 549.07. The lowest was 19.85. And the median was 134.62.


AULSF's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 32.19
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-01), Austar Lifesciences's share price is $0.005. Austar Lifesciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.03. Therefore, Austar Lifesciences's PE Ratio for today is At Loss.

As of today (2024-06-01), Austar Lifesciences's share price is $0.005. Austar Lifesciences's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.00. Therefore, Austar Lifesciences's PE Ratio without NRI for today is At Loss.

During the past 11 years, Austar Lifesciences's highest PE Ratio without NRI was 1020.00. The lowest was 0.00. And the median was 117.64.


Austar Lifesciences Price-to-Owner-Earnings Historical Data

The historical data trend for Austar Lifesciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Price-to-Owner-Earnings Chart

Austar Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Austar Lifesciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Austar Lifesciences's Price-to-Owner-Earnings

For the Medical Devices subindustry, Austar Lifesciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Austar Lifesciences's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Austar Lifesciences's Price-to-Owner-Earnings falls into.



Austar Lifesciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Austar Lifesciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.005/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Austar Lifesciences  (OTCPK:AULSF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Austar Lifesciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Austar Lifesciences (Austar Lifesciences) Business Description

Traded in Other Exchanges
Address
No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN
Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Austar Lifesciences (Austar Lifesciences) Headlines

No Headlines